Word: site
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...excavations in Jerusalem are overseen by the IAA, and its director, ex-General Shuka Dorfman explained to TIME that while Elad manages and funds more than a dozen digs around Jerusalem, an IAA archaeologist is always on-site to analyze findings. Dorfman concedes that the settler organization's interpretation of its findings in Silwan "is different from ours." He adds: "They emphasize only the Jewish heritage." Sometimes, according to archaeologist Mizrahi, the Elad-sponsored digs ignore other strata of Jerusalem's multi-cultural history. "They're only focusing on one tradition - the Jewish one," he says...
...Western Wall. The Waqf - Jerusalem's Islamic authority - made Jews furious in 1999 when they built an underground mosque inside the Haram al-Sharif and, according to irate Israeli scholars, gouged out "several hundred" trucks' worth of debris, destroying evidence that might shed light on Judaism's holiest site. "This was politically motivated," fumes archaeologist Gabriel Barkay, who leads a team of volunteers that has spent years sifting through large mounds of material from the sacred precinct that was rescued from a city dump. "In places where you should have used a toothbrush, they used a bulldozer...
...There have been times, in fact, when the Chinese government, in the form of its state-owned media, has turned on Baidu. In 2008, CCTV, the powerful state-run television network, aired reports on the site's habit of serving up unlicensed doctors and illegal pharmacies in response to medical queries on its engine. It turned out those were Baidu advertisers. The disclosures hit directly at the site's integrity and temporarily crushed the stock. Baidu has only just finished rolling out a new program that will delineate paid results from general searches, but that remedy has taken more time...
...kidney cancer, his doctor handed him a prescription slip. On it, he'd scribbled ACOR.org. Within 11 minutes of submitting his first post to the Association of Cancer Online Resources, deBronkart, a software marketer in Nashua, N.H., received recommendations for top specialists - with links included - from patients on the site's kidney-cancer list. Within half an hour, an e-mail arrived from an ACOR member suggesting which scans might be appropriate and offering details about interleukin-2, the only treatment at the time that resembled a cure. "This is scary, terrifying," wrote another respondent, "but this list offers...
...response to the publication of a small study indicating that lithium helps people with ALS, the site evaluated the collective experience of its members who had taken the drug and determined that lithium didn't work - a conclusion it reached six months ahead of similar findings from conventional clinical trials. (In an interesting sign of the times, PatientsLikeMe presented its observations in December at the international ALS symposium in Berlin.) Free to patients, the for-profit venture sells pharmaceutical companies the blinded data it compiles from its members about drug safety and efficacy. (See "The Year in Health 2009: From...